
Hienra Drugs Private Limited
Founded in 2007 and headquartered in Telangana, India.
Founded in 2007 and headquartered in Telangana, India.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24232TG2007PTC052919
052919
Private Limited Indian Non-Government Company
22 Feb 2007
31 Dec 2020
31 Mar 2020
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shanmukha Motati ![]() | Director | 22-Feb-2007 | Current |
Nagamani Motati ![]() | Director | 22-Feb-2007 | Current |
Hienra Drugs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 2.5%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
In 2017, Hienra Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Shanmukha Motati is a mutual person
Shanmukha Motati is a mutual person
Shanmukha Motati is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hienra Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hienra Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hienra Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hienra Drugs Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Hienra Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Shanmukha Chaitanya Reddy Motati was appointed as a Director was appointed as a Director on 22 Feb 2007 & has been associated with this company since 18 years 1 month .
Nagamani Motati was appointed as a Director was appointed as a Director on 22 Feb 2007 & has been associated with this company since 18 years 1 month .
Hienra Drugs Private Limited was registered on 22 Feb 2007 with Roc Hyderabad & aged 18 years 1 month as per MCA records.
Hienra Drugs Private Limited was incorporated on 22 Feb 2007.
The authorized share capital of Hienra Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Hienra Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Hienra Drugs Private Limited is 2-1-745 #101 Manohar Apartments, Vidyanagar, Hyderabad, Telangana, India, 500044.
The corporate identification number (CIN) of Hienra Drugs Private Limited is U24232TG2007PTC052919 and the company number is 052919 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2020 indicates that The net worth of Hienra Drugs Private Limited has experienced an downturn of -2.50%.
The most recent Balance Sheet for Hienra Drugs Private Limited was filed with the ROC on 31 Mar 2020.